Patents Assigned to Stratagene California
  • Patent number: 6803216
    Abstract: The invention relates to compositions and methods for nucleic acid PCR mutagenesis using novel error-prone DNA polymerases and a PCR enhancing factor. The invention also relates to compositions and methods for nucleic mutagenesis with two or more DNA polymerases lacking or exhibiting reduced exonuclease activity. The invention further relates to kit format of said compositions for PCR mutagenesis.
    Type: Grant
    Filed: May 23, 2002
    Date of Patent: October 12, 2004
    Assignee: Stratagene California
    Inventors: Holly H. Hogrefe, Janice M. Cline
  • Patent number: 6207810
    Abstract: A rapid method for generating a set of discrete DNA amplification products characteristic of a genome as a “fingerprint” comprises the steps of: priming target nucleic acid of a genome or from a cellular RNA preparation with an single-stranded primer to form primed nucleic acid such that a substantial degree of internal-mismatching occurs between the primer and the target nucleic acid; amplifying the primed nucleic acid by performing at least one cycle of polymerase chain reaction amplification; and amplifying the product of step (2) by performing at least about 10 cycles of polymerase chain reaction amplification. The method is known as the arbitrarily primed polymerase chain reaction (AP-PCR) method and is suitable for the identification of bacterial species and strains, mammals and plants.
    Type: Grant
    Filed: November 16, 1993
    Date of Patent: March 27, 2001
    Assignee: Stratagene and California Institute of Biological Research
    Inventors: Michael McClelland, John T. Welsh
  • Patent number: 5861245
    Abstract: A rapid method for generating a set of discrete DNA amplification products characteristic of a genome as a "fingerprint" comprises the steps of: priming target nucleic acid of a genome with an single-stranded primer to form primed nucleic acid such that a substantial degree of internal-mismatching occurs between the primer and the target nucleic acid; amplifying the primed nucleic acid by performing at least one cycle of polymerase chain reaction amplification; and amplifying the product of step (2) by performing at least about 10 cycles of polymerase chain reaction amplification. The method is known as the arbitrarily primed polymerase chain reaction (AP-PCR) method and is suitable for the identification of bacterial species and strains, including Staphylococcus and Streptococcus species, mammals and plants.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: January 19, 1999
    Assignee: Stratagene & California Institute Of Biological Research
    Inventors: Michael McClelland, John Thomas Welsh, Joseph A. Sorge